IL6 and COVID-19: A moderate but significant elevation of IL-6 in the plasma of COVID-19-S patients might be an indicator of hypercytokinemia in lung and other organs, and intervention of the IL-6-mediated pathological cascade may reduce or alleviate the immune attack found in the lungs of COVID-19-S patients.